BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373:850-861. [PMID: 19269522 DOI: 10.1016/s0140-6736(09)60487-6] [Cited by in Crossref: 209] [Cited by in F6Publishing: 94] [Article Influence: 16.1] [Reference Citation Analysis]
Number Citing Articles
1 Goldberg A, Gerkin RD, Young M. Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins. Dig Dis Sci 2015;60:2058-62. [PMID: 25680872 DOI: 10.1007/s10620-015-3569-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 Trembath DG, Shaheen NJ, O'Neill S, Weck K, Greene KG. Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia. BMC Res Notes 2013;6:457. [PMID: 24220097 DOI: 10.1186/1756-0500-6-457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Wang XW, Wei W, Wang WQ, Zhao XY, Guo H, Fang DC. RING finger proteins are involved in the progression of barrett esophagus to esophageal adenocarcinoma: a preliminary study. Gut Liver 2014;8:487-94. [PMID: 25228972 DOI: 10.5009/gnl13133] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
4 Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in barrett’s esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila). 2010;3:1176-1186. [PMID: 20651033 DOI: 10.1158/1940-6207.capr-09-0265] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
5 Qumseya B, Bukannan A, Rosasco R, Liu X, Qumseya A. Surveillance of Barrett’s esophagus using wide-area transepithelial sampling: systematic review and meta-analysis. Endosc Int Open 2022;10:E394-402. [DOI: 10.1055/a-1783-9015] [Reference Citation Analysis]
6 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls. J Neurogastroenterol Motil 2016;22:630-42. [PMID: 27557545 DOI: 10.5056/jnm16019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Guthikonda A, Cotton CC, Madanick RD, Spacek MB, Moist SE, Ferrell K, Dellon ES, Shaheen NJ. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation. Am J Gastroenterol 2017;112:87-94. [PMID: 27725648 DOI: 10.1038/ajg.2016.451] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
8 Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, Wilson KT, Zaika A, El-Rifai W. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut. 2012;61:1250-1260. [PMID: 22157330 DOI: 10.1136/gutjnl-2011-301078] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
9 Zhou Z, Lu H, Zhu S, Gomaa A, Chen Z, Yan J, Washington K, El-Rifai W, Dang C, Peng D. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage. J Exp Clin Cancer Res 2019;38:13. [PMID: 30626422 DOI: 10.1186/s13046-018-1021-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
10 Wang Y, Zhang Y, Herman JG, Linghu E, Guo M. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development. Oncotarget 2017;8:70035-48. [PMID: 29050260 DOI: 10.18632/oncotarget.19550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
11 Garud SS, Keilin S, Cai Q, Willingham FF. Diagnosis and management of Barrett's esophagus for the endoscopist. Therap Adv Gastroenterol 2010;3:227-38. [PMID: 21180605 DOI: 10.1177/1756283X10365439] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, Burdick JS, Abrams JA, Wang KK, Mallat D, Johnston MH, Zfass AM, Smith JO, Barthel JS, Lightdale CJ. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010;71:680-5. [PMID: 20363409 DOI: 10.1016/j.gie.2010.01.018] [Cited by in Crossref: 174] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
13 Zhu Y, Terry NG, Wax A. Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2012;6:37-41. [PMID: 22149580 DOI: 10.1586/egh.11.83] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Lam C, Liu WF, Bel RD, Chan K, Miller L, Brown MC, Chen Z, Cheng D, Patel D, Xu W, Darling GE, Liu G. Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments. Dis Esophagus 2017;30:1-7. [PMID: 26822871 DOI: 10.1111/dote.12456] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Yates M, Cheong E, Luben R, Igali L, Fitzgerald R, Khaw KT, Hart A. Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci. 2014;59:1552-1559. [PMID: 24500448 DOI: 10.1007/s10620-013-3024-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
16 Chen J, Wong S, Nathanson MH, Jain D. Evaluation of Barrett esophagus by multiphoton microscopy. Arch Pathol Lab Med 2014;138:204-12. [PMID: 24476518 DOI: 10.5858/arpa.2012-0675-OA] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Lottrup C, Olesen SS, Drewes AM. The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment. Gastroenterol Res Pract 2011;2011:910420. [PMID: 21826137 DOI: 10.1155/2011/910420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Barret M, Pratico CA, Camus M, Beuvon F, Jarraya M, Nicco C, Mangialavori L, Chaussade S, Batteux F, Prat F. Amniotic membrane grafts for the prevention of esophageal stricture after circumferential endoscopic submucosal dissection. PLoS One. 2014;9:e100236. [PMID: 24992335 DOI: 10.1371/journal.pone.0100236] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
19 Lin L, Bass AJ, Lockwood WW, Wang Z, Silvers AL, Thomas DG, Chang AC, Lin J, Orringer MB, Li W, Glover TW, Giordano TJ, Lam WL, Meyerson M, Beer DG. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc Natl Acad Sci U S A 2012;109:4251-6. [PMID: 22375031 DOI: 10.1073/pnas.1011989109] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
20 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
21 Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2013;34:2750-2756. [PMID: 23996928 DOI: 10.1093/carcin/bgt286] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
22 O’Connell K, Velanovich V. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus. Surg Endosc. 2011;25:830-834. [PMID: 20676687 DOI: 10.1007/s00464-010-1270-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
23 Li M, Anastassiades CP, Joshi B, Komarck CM, Piraka C, Elmunzer BJ, Turgeon DK, Johnson TD, Appelman H, Beer DG. Affinity peptide for targeted detection of dysplasia in Barrett’s esophagus. Gastroenterology. 2010;139:1472-1480. [PMID: 20637198 DOI: 10.1053/j.gastro.2010.07.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 5.4] [Reference Citation Analysis]
24 Jovov B, Shaheen NJ, Orlando GS, Djukic Z, Orlando RC. Defective barrier function in neosquamous epithelium. The American journal of gastroenterology. 2013;108:386-391. [PMID: 23318477 DOI: 10.1038/ajg.2012.440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
25 Klaver E, van der Wel MJ, Meijer SL, Bergman JJ, Pouw RE. Chapter 2: Role of pathologic confirmation for Barrett′s esophagus and dysplasia. Techniques in Gastrointestinal Endoscopy 2018;20:62-9. [DOI: 10.1016/j.tgie.2018.03.002] [Reference Citation Analysis]
26 Saracco M, Savarino V, Bodini G, Saracco GM, Pellicano R. Gastroesophageal reflux disease: key messages for clinicians. Minerva Gastroenterol (Torino) 2021;67:390-403. [PMID: 33103406 DOI: 10.23736/S1121-421X.20.02783-X] [Reference Citation Analysis]
27 Barakat EAME, Abbas NF, El-kholi NY. Primary bile reflux gastritis versus Helicobacter pylori gastritis: a comparative study. Egypt J Intern Med 2018;30:23-7. [DOI: 10.4103/ejim.ejim_42_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World J Gastroenterol 2017; 23(30): 5508-5518 [PMID: 28852310 DOI: 10.3748/wjg.v23.i30.5508] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
30 Carrossini N, Meireles Da Costa N, Andrade-Barreto E, Sousa VPL, Nicolau-Neto P, Souza-Santos PT, Mansur GR, Wernersbach L, Bozza PT, Viola JPB, Ribeiro Pinto LF. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors. Sci Rep 2021;11:981. [PMID: 33441691 DOI: 10.1038/s41598-020-80035-4] [Reference Citation Analysis]
31 Peng DF, Hu TL, Soutto M, Belkhiri A, El-Rifai W. Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis. J Cancer 2014;5:510-7. [PMID: 24963355 DOI: 10.7150/jca.9215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
32 Merrell AJ, Stanger BZ. Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nat Rev Mol Cell Biol 2016;17:413-25. [PMID: 26979497 DOI: 10.1038/nrm.2016.24] [Cited by in Crossref: 156] [Cited by in F6Publishing: 177] [Article Influence: 26.0] [Reference Citation Analysis]
33 Krarup AL, Olesen SS, Funch-Jensen P, Gregersen H, Drewes AM. Proximal and distal esophageal sensitivity is decreased in patients with Barrett’s esophagus. World J Gastroenterol 2011; 17(4): 514-521 [PMID: 21274382 DOI: 10.3748/wjg.v17.i4.514] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
34 Zhu Y, Terry NG, Woosley JT, Shaheen NJ, Wax A. Design and validation of an angle-resolved low-coherence interferometry fiber probe for in vivo clinical measurements of depth-resolved nuclear morphology. J Biomed Opt 2011;16:011003. [PMID: 21280890 DOI: 10.1117/1.3520130] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
35 Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A. hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance. Oncotarget. 2016;7:59535-59547. [PMID: 27517748 DOI: 10.18632/oncotarget.11149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
36 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W. Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Gut 2014;63:540-51. [PMID: 23580780 DOI: 10.1136/gutjnl-2013-304612] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
38 Frandsen LT, Westmark S, Melgaard D, Krarup AL. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate. United European Gastroenterol J 2021;9:910-8. [PMID: 34477326 DOI: 10.1002/ueg2.12146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Peng DF, Hu TL, Soutto M, Belkhiri A, El-Rifai W. Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis. Carcinogenesis 2014;35:1620-8. [PMID: 24692067 DOI: 10.1093/carcin/bgu083] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
40 Shiota S, Singh S, Anshasi A, El-Serag HB. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1907-1918. [PMID: 26260107 DOI: 10.1016/j.cgh.2015.07.050] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
41 Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc 2022:S0016-5107(22)00002-5. [PMID: 34998796 DOI: 10.1016/j.gie.2021.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Luigiano C, Iabichino G, Eusebi LH, Arena M, Consolo P, Morace C, Opocher E, Mangiavillano B. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review. Gastroenterol Res Pract. 2016;2016:4249510. [PMID: 28070182 DOI: 10.1155/2016/4249510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
43 Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800-808. [PMID: 27757547 DOI: 10.1007/s00535-016-1275-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
44 Sawyer JK, Cohen E, Fox DT. Interorgan regulation of Drosophila intestinal stem cell proliferation by a hybrid organ boundary zone. Development 2017;144:4091-102. [PMID: 28947534 DOI: 10.1242/dev.153114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
45 Zhang T, Wang Q, Ma WY, Wang K, Chang X, Johnson ML, Bai R, Bode AM, Foster NR, Falk GW, Limburg PJ, Iyer PG, Dong Z. Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development. EBioMedicine 2019;49:145-56. [PMID: 31707149 DOI: 10.1016/j.ebiom.2019.10.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC. A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma. Dis Esophagus. 2019;32. [PMID: 30496496 DOI: 10.1093/dote/doy102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
47 Barghash A, Golob-Schwarzl N, Helms V, Haybaeck J, Kessler SM. Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma. Oncotarget 2016;7:49743-50. [PMID: 27391348 DOI: 10.18632/oncotarget.10439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
48 Eluri S, Klaver E, Duits LC, Jackson SA, Bergman JJ, Shaheen NJ. Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma. Dis Esophagus 2018;31. [PMID: 29635420 DOI: 10.1093/dote/doy026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
50 Lee HS, Jeon SW. Barrett esophagus in Asia: same disease with different pattern. Clin Endosc. 2014;47:15-22. [PMID: 24570879 DOI: 10.5946/ce.2014.47.1.15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
51 Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC, Whiteman DC, Vaughan TL, Thrift AP; Stomach and Oesophageal Cancer Study (SOCS) consortium. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology 2018;154:1273-1281.e3. [PMID: 29247777 DOI: 10.1053/j.gastro.2017.12.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
52 Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ. Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry. Gastrointest Endosc. 2015;82:276-284. [PMID: 25841575 DOI: 10.1016/j.gie.2015.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Suchniak-Mussari K, Dye CE, Moyer MT, Mathew A, McGarrity TJ, Gagliardi EM, Maranki JL, Levenick JM. Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett’s esophagus. World J Gastrointest Endosc 2017; 9(9): 480-485 [PMID: 28979713 DOI: 10.4253/wjge.v9.i9.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Wong RSY. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Adv Pharmacol Sci 2019;2019:3418975. [PMID: 30838040 DOI: 10.1155/2019/3418975] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
55 Lee SW, Lien HC, Chang CS, Lin MX, Chang CH, Ko CW. Benefits of the Seattle biopsy protocol in the diagnosis of Barrett’s esophagus in a Chinese population. World J Clin Cases 2018; 6(14): 753-758 [PMID: 30510939 DOI: 10.12998/wjcc.v6.i14.753] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
56 Lin J, Myers AL, Wang Z, Nancarrow DJ, Ferrer-Torres D, Handlogten A, Leverenz K, Bao J, Thomas DG, Wang TD, Orringer MB, Reddy RM, Chang AC, Beer DG, Lin L. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma. Oncotarget 2015;6:22239-57. [PMID: 26068949 DOI: 10.18632/oncotarget.4161] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
57 Iida T, Wagatsuma K, Hirayama D, Nakase H. Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases? Int J Mol Sci 2017;19:E7. [PMID: 29267211 DOI: 10.3390/ijms19010007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
58 Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021;31:27-41. [PMID: 33213798 DOI: 10.1016/j.giec.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Kan T, Meltzer SJ. MicroRNAs in Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol. 2009;9:727-732. [PMID: 19773200 DOI: 10.1016/j.coph.2009.08.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
60 Ishihara R, Yamamoto S, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Iishi H. Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective. Ann Transl Med 2014;2:24. [PMID: 25333000 DOI: 10.3978/j.issn.2305-5839.2014.02.03] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
61 Triantos C, Koukias N, Karamanolis G, Thomopoulos K. Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone? World J Gastroenterol 2015;21:5762-7. [PMID: 26019440 DOI: 10.3748/wjg.v21.i19.5762] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
62 Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015;149:1599-1606. [PMID: 26296479 DOI: 10.1053/j.gastro.2015.08.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
63 Denver P, Donnelly M, Murray LJ, Anderson LA. Psychosocial factors and their association with reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma. World J Gastroenterol 2013; 19(11): 1770-1777 [PMID: 23555165 DOI: 10.3748/wjg.v19.i11.1770] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010; 16(5): 531-537 [PMID: 20128019 DOI: 10.3748/wjg.v16.i5.531] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
65 Dall'Olmo L, Fassan M, Dassie E, Scarpa M, Realdon S, Cavallin F, Cagol M, Battaglia G, Pizzi M, Guzzardo V, Franceschinis E, Pasut G, Rugge M, Zaninotto G, Realdon N, Castoro C. Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. PLoS One 2014;9:e112862. [PMID: 25415190 DOI: 10.1371/journal.pone.0112862] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
66 Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18-52; quiz e13. [PMID: 21376939 DOI: 10.1053/j.gastro.2011.01.031] [Cited by in Crossref: 766] [Cited by in F6Publishing: 517] [Article Influence: 69.6] [Reference Citation Analysis]
67 Tuttle R, Nurkin SJ, Hochwald SN. Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA. Biomed Res Int 2014;2014:642063. [PMID: 25140320 DOI: 10.1155/2014/642063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
68 Li N, Pasricha S, Bulsiewicz WJ, Pruitt RE, Komanduri S, Wolfsen HC, Chmielewski GW, Corbett FS, Chang KJ, Shaheen NJ. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus. 2016;29:537-543. [PMID: 26121935 DOI: 10.1111/dote.12386] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
69 Xu J, Yin Z, Yang L, Wu F, Fan J, Huang Q, Jin Y, Yang G. Evidence that dysplasia related microRNAs in Barrett's esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma. Aging (Albany NY) 2020;12:17062-78. [PMID: 32903213 DOI: 10.18632/aging.103634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Spużak J, Jankowski M, Kubiak K, Glińska-Suchocka K, Ciaputa R. A modified Sydney system for the diagnosis of chronic gastritis in dogs. Acta Vet Scand 2020;62:44. [PMID: 32787889 DOI: 10.1186/s13028-020-00542-2] [Reference Citation Analysis]
71 Terry NG, Zhu Y, Rinehart MT, Brown WJ, Gebhart SC, Bright S, Carretta E, Ziefle CG, Panjehpour M, Galanko J. Detection of dysplasia in Barrett’s esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology. 2011;140:42-50. [PMID: 20854820 DOI: 10.1053/j.gastro.2010.09.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
72 Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB. The association between Barrett’s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter. 2012;17:163-175. [PMID: 22515353 DOI: 10.1111/j.1523-5378.2011.00931.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
73 Lee SW, Lien HC, Peng YC, Lin MX, Ko CW, Chang CS. The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus. JGH Open 2018;2:214-6. [PMID: 30483592 DOI: 10.1002/jgh3.12075] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Chapelon E, Barry C, Hubert T, Com-Ruelle L, Duclos J, Mattar L, Falissard B, Huas C, Godart N. Health in adulthood after severe anorexia nervosa in adolescence: a study of exposed and unexposed women. Eat Weight Disord 2021;26:1389-97. [PMID: 32572843 DOI: 10.1007/s40519-020-00940-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Asreah RH, Abdullhameed A. Risk factors of erosive esophagitis and barrett's esophagus in patients with reflux symptoms. Med J Islam Repub Iran 2021;35:75. [PMID: 34290999 DOI: 10.47176/mjiri.35.75] [Reference Citation Analysis]
76 Sostres C, Lacarta P, Lanas A. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?]. Gastroenterol Hepatol 2013;36:520-6. [PMID: 23453559 DOI: 10.1016/j.gastrohep.2012.11.010] [Reference Citation Analysis]
77 Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg 2017;6:75-87. [PMID: 28446996 DOI: 10.21037/acs.2017.03.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
78 Bhardwaj V, Gokulan RC, Horvat A, Yermalitskaya L, Korolkova O, Washington KM, El-Rifai W, Dikalov SI, Zaika AI. Activation of NADPH oxidases leads to DNA damage in esophageal cells. Sci Rep 2017;7:9956. [PMID: 28855537 DOI: 10.1038/s41598-017-09620-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
79 Li K, Liang W, Mavadia-Shukla J, Park HC, Li D, Yuan W, Wan S, Li X. Super-achromatic optical coherence tomography capsule for ultrahigh-resolution imaging of esophagus. J Biophotonics 2019;12:e201800205. [PMID: 30302923 DOI: 10.1002/jbio.201800205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 Eluri S, Brugge WR, Daglilar ES, Jackson SA, Styn MA, Callenberg KM, Welch DC, Barr TM, Duits LC, Bergman JJ. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol. 2015;110:828-834. [PMID: 26010308 DOI: 10.1038/ajg.2015.152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
81 Elliott DRF, Walker AW, O'Donovan M, Parkhill J, Fitzgerald RC. A non-endoscopic device to sample the oesophageal microbiota: A case-control study. Lancet Gastroenterol Hepatol. 2017;2:32-42. [PMID: 28404012 DOI: 10.1016/s2468-1253(16)30086-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
82 Runge TM, Shaheen NJ, Djukic Z, Hallquist S, Orlando RC. Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium. Dig Dis Sci 2016;61:3169-75. [PMID: 27659669 DOI: 10.1007/s10620-016-4315-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Jones HG, Jenkins G, Williams N, Griffiths P, Chambers P, Beynon J, Harris D. Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer. World J Surg 2017;41:1375-83. [PMID: 28097409 DOI: 10.1007/s00268-016-3860-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
84 Kadri SR, Lao-Sirieix P, O’Donovan M, Debiram I, Das M, Blazeby JM, Emery J, Boussioutas A, Morris H, Walter FM. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ. 2010;341:c4372. [PMID: 20833740 DOI: 10.1136/bmj.c4372] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 16.8] [Reference Citation Analysis]
85 Max Almond L, Barr H. Management controversies in Barrett’s oesophagus. J Gastroenterol. 2013;Jun 5; Epub ahead of print. [PMID: 23736794 DOI: 10.1007/s00535-013-0816-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Li X, Kleeman S, Coburn SB, Fumagalli C, Perner J, Jammula S, Pfeiffer RM, Orzolek L, Hao H, Taylor PR, Miremadi A, Galeano-Dalmau N, Lao-Sirieix P, Tennyson M, MacRae S, Cook MB, Fitzgerald RC. Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus. Gastroenterology. 2018;155:771-783.e3. [PMID: 29906417 DOI: 10.1053/j.gastro.2018.05.050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
87 Moon H, Zhu J, Donahue LR, Choi E, White AC. Krt5+/Krt15+ foregut basal progenitors give rise to cyclooxygenase-2-dependent tumours in response to gastric acid stress. Nat Commun 2019;10:2225. [PMID: 31110179 DOI: 10.1038/s41467-019-10194-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
88 Brosnan C, Hannan E, Duggan W, Harding T, Maguire D, Stafford AT. Diagnostic Inaccuracies of Barrett's Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance? Cureus 2020;12:e9850. [PMID: 32953357 DOI: 10.7759/cureus.9850] [Reference Citation Analysis]
89 Kaul V, Bittner K, Ullah A, Kothari S. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center. Dis Esophagus 2020;33:doz095. [PMID: 31909783 DOI: 10.1093/dote/doz095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lee SA, Liu F, Yun DY, Riordan SM, Tay ACY, Liu L, Lee CS, Zhang L. Campylobacter concisus upregulates PD-L1 mRNA expression in IFN-γ sensitized intestinal epithelial cells and induces cell death in esophageal epithelial cells. J Oral Microbiol 2021;13:1978732. [PMID: 34552702 DOI: 10.1080/20002297.2021.1978732] [Reference Citation Analysis]
91 Liu D. LYN, a Key Gene From Bioinformatics Analysis, Contributes to Development and Progression of Esophageal Adenocarcinoma. Med Sci Monit Basic Res 2015;21:253-61. [PMID: 26708841 DOI: 10.12659/MSMBR.895463] [Cited by in Crossref: 53] [Cited by in F6Publishing: 5] [Article Influence: 7.6] [Reference Citation Analysis]
92 Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus. J Gastroenterol 2019;54:1-9. [PMID: 29961130 DOI: 10.1007/s00535-018-1491-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
93 Lim L, Streutker CJ, Marcon N, Cirocco M, Lao A, Iakovlev VV, DaCosta R, Wilson BC. A feasibility study of photoacoustic imaging of ex vivo endoscopic mucosal resection tissues from Barrett's esophagus patients. Endosc Int Open 2017;5:E775-83. [PMID: 28791328 DOI: 10.1055/s-0043-111790] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
94 Xu E, Gong Y, Gu J, Jie L, Ajani JA, Wu X. Risk assessment of esophageal adenocarcinoma using γ-H2AX assay. Cancer Epidemiol Biomarkers Prev 2013;22:1797-804. [PMID: 23904462 DOI: 10.1158/1055-9965.EPI-13-0485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
95 Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus. J Gastroenterol Hepatol 2020;35:211-7. [PMID: 31396997 DOI: 10.1111/jgh.14827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ray D, Ray P, Ferrer-Torres D, Wang Z, Nancarrow D, Yoon HW, San Martinho M, Hinton T, Owens S, Thomas D, Jiang H, Lawrence TS, Lin J, Lagisetty K, Chang AC, Beer DG. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells. Gastroenterology 2020;158:583-597.e1. [PMID: 31715145 DOI: 10.1053/j.gastro.2019.10.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
97 Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013;6:196-205. [PMID: 23466817 DOI: 10.1158/1940-6207.capr-12-0276] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
98 Arcidiacono D, Zaramella A, Fabris F, Sánchez-Rodríguez R, Nucci D, Fassan M, Nardi M, Benna C, Cristofori C, Morbin T, Pucciarelli S, Fantin A, Realdon S. Insulin/IGF-1 Signaling Is Downregulated in Barrett's Esophagus Patients Undergoing a Moderate Calorie and Protein Restriction Program: A Randomized 2-Year Trial. Nutrients 2021;13:3638. [PMID: 34684639 DOI: 10.3390/nu13103638] [Reference Citation Analysis]
99 Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015;44:203-231. [PMID: 26021191 DOI: 10.1016/j.gtc.2015.02.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 82] [Article Influence: 14.9] [Reference Citation Analysis]
100 Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF. Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry. J Gastrointest Surg 2013;17:21-8; discussion p.28-9. [PMID: 22965650 DOI: 10.1007/s11605-012-2001-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
101 Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Michopoulos S, Savva S, Tzias V, Zouboulis-Vafiadis I, Kamberoglou D. Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter? Dig Dis Sci. 2012;57:1190-1196. [PMID: 22147251 DOI: 10.1007/s10620-011-1990-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
102 Lim CH, Lee PC, Lim E, Tan J, Chan WH, Tan HC, Ganguly S, Tham KW, Eng A. Correlation Between Symptomatic Gastro-Esophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) Post-vertical Sleeve Gastrectomy (VSG). Obes Surg 2019;29:207-14. [PMID: 30238218 DOI: 10.1007/s11695-018-3509-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
103 Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and management of Barrett's oesophagus. BMJ. 2010;341:c4551. [PMID: 20833742 DOI: 10.1136/bmj.c4551] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
104 Somerville M, Pitt M. Surveillance of Barrett's oesophagus: do we yet know whether it is worthwhile? Frontline Gastroenterol 2010;1:88-93. [PMID: 28839554 DOI: 10.1136/fg.2009.000307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Gonzalez S, Yu WM, Smith MS, Slack KN, Rotterdam H, Abrams JA, Lightdale CJ. Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett’s esophagus. Gastrointest Endosc. 2010;72:935-940. [PMID: 21034895 DOI: 10.1016/j.gie.2010.07.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
106 Melgaard D, Westmark S, Laurberg PT, Krarup AL. A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education - a population-based cross-sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark Region. United European Gastroenterol J 2021;9:688-98. [PMID: 34117730 DOI: 10.1002/ueg2.12092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]